Clendenen, T. V.
Hu, S.
Afanasyeva, Y.
Askenazi, M.
Koenig, K. L.
Hulett, T.
Liu, M.
Liu, S.
Wu, F.
Zeleniuch-Jacquotte, A.
Chen, Y.
Funding for this research was provided by:
National Cancer Institute (U01CA182934, U01CA182934)
Article History
Received: 29 December 2021
Accepted: 30 March 2022
First Online: 13 April 2022
Competing interests
: S.H., T.H., and S.L. are employed by CDI laboratories, which created the HuProtTM platform for autoantibody assays used in this study. M.A. is a consultant for CDI Laboratories and the owner of Biomedical Hosting, LLC. T.V.C., Y.A., K.L.K., M.L., F.W., A.Z.J., and Y.C. declare no competing interests.